Clinical Research Fastrack

Home News Alcanza Commemorates Juneteenth with Scholarship Program

Alcanza Commemorates Juneteenth with Scholarship Program


BOSTON, M.A. – June 06 2023 – As part of its mission to expand diversity and inclusion in clinical research, Alcanza Clinical Research announces funding and mentorship to support African American individuals pursuing clinical research careers, and drive broader representation in the workforce.

For the second consecutive year in recognition of Juneteenth 2022, the holiday celebrating the emancipation of those who had been enslaved in the United States, Alcanza will partner with Clinical Research Fastrack to provide scholarship funding to enable two African American students to attend the Clinical Research Fastrack Bootcamp Training Program, a highly intensive, accelerated course that prepares new professionals for the field of clinical research. 

“We strongly believe in investing in the future of clinical research talent, which begins by supporting aspiring young minds,” said Carlos Orantes, Chief Executive Officer of Alcanza. “In honoring Juneteenth, we are delighted to leverage the Fastrack program. We see this as a step towards creating more diversity and representation in the field of clinical research, while helping the clinical research industry build a talent pipeline that meets the changing needs of research.”

As a trusted education provider for hundreds of the top research sites, Clinical Research Fastrack graduates have a significant likelihood of receiving job opportunities at research sites and sponsors as well as contract and academic research organizations. In addition to foundational instruction, the recipient will also receive mentorship opportunities from Alcanza’s network of clinical research professionals and Clinical Research Fastrack Directors.

“This generous scholarship from Alcanza Clinical Research truly encapsulates the spirit of Juneteenth, creating opportunities and fostering inclusivity,” said David Silberman, CEO and Founder of Clinical Research Fastrack. “We are thrilled for our students and deeply grateful to Alcanza for their commitment to education and diversity.”

Both scholarships will cover partial tuition for the recipients in an upcoming cohort. Alcanza and Fastrack will be collaborating to select the scholarship winners, with the announcement expected to be made in the coming weeks.

About Alcanza Clinical Research 

Alcanza Clinical Research is the next-generation site network established to support the most significant demands in our industry: diverse patient access, efficient enrollment performance, and clinical quality.  It practices inclusive research that delivers education and a range of clinical trial opportunities to all people on their terms.  Located in Florida, Massachusetts, Michigan, New Hampshire, South Carolina and Virginia, Alcanza specializes in conditions across psychiatry, neurology, dermatology and infectious disease therapeutic areas.

The Alcanza network includes six multi-specialty organizations in eight locations.

ActivMed Practices and Research and Allcutis Research conduct Phase I-IV research across multiple locations in Massachusetts and New Hampshire.

Boston Clinical Trials serves the Boston, MA metro area with Phase II-IV studies.

Charlottesville Medical Research serves central Virginia patients with Phase II-IV studies.

Coastal Carolina Research Center offers Phase I-IV studies from the largest multi-therapeutic research site in the Southeast United States. 

Quest Research Institute provides Phase I-IV studies in Southeastern Michigan.

Vertex Clinical Research specializes in Phase II-IV studies involving neurological indications.

About Clinical Research Fastrack

Clinical Research Fastrack trains aspiring Clinical Research professionals and connects them with leading research organizations to elevate the efficacy of clinical trials. Ultimately, qualified clinical researchers lead to new and better treatments for debilitating conditions like cancer, heart disease, diabetes, Alzheimer’s, chronic respiratory diseases, tumors, septicemia, liver disease, Parkinson’s, obesity, arthritis, and so many more.


Alcanza Public Relations

[email protected]